Pneumopericardium after bilateral lung transplantation

Por Taccone, F S, Marechal, R, Appoloni, O
Publicado em 2006

Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study

Por Demols, A, Peeters, M, Polus, M, Marechal, R, Gay, F, Monsaert, E, Hendlisz, A, Van Laethem, J L
Publicado em 2006

DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer

Por Drouillard, A, Puleo, F, Bachet, J B, Ouazzani, S, Calomme, A, Demetter, P, Verset, G, Van Laethem, J L, Maréchal, R
Publicado no Br J Cancer (2016)

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma

Por Maréchal, R, Demetter, P, Nagy, N, Berton, A, Decaestecker, C, Polus, M, Closset, J, Devière, J, Salmon, I, Van Laethem, J-L
Publicado em 2009

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma

Por Maréchal, R, Demetter, P, Nagy, N, Berton, A, Decaestecker, C, Polus, M, Closset, J, Devière, J, Salmon, I, Van Laethem, J-L
Publicado em 2010